Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2018-07-10 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
关于获得政府补助的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (695 characters) regarding the receipt of a government subsidy by the company 中粮生物化学（安徽）股份有限公司. It details the amount, source, and accounting treatment of the subsidy, and includes a caution about investment risk. There is no financial statement or comprehensive report included, nor is there a mention of an attached or forthcoming report. The content is a regulatory announcement about a specific financial event (government subsidy) impacting the company's earnings. It does not fit into categories like Annual Report, Interim Report, or Earnings Release, which require substantive financial data. It is not a certification or officer attestation. Given the nature and length, the best fit is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2018-07-10 Chinese
桦力投资有限公司审计报告
Regulatory Filings
2018-06-27 Chinese
七届十次董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 10th meeting of the 7th board of directors of COFCO Biochemical (Anhui) Co., Ltd. It includes voting results on various proposals such as approval of updated audit reports related to a major asset acquisition, approval of updated transaction reports, approval of subsidiary cancellation, and approval to convene an extraordinary shareholders meeting. The document references audit reports and transaction reports but does not contain the reports themselves. It is a formal board meeting resolution announcement, not a full audit report or annual report. The content focuses on board decisions and approvals, which fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and is a formal announcement of board resolutions, not a report publication announcement or regulatory filing. Therefore, the best classification is MANG with high confidence.
2018-06-27 Chinese
发行股份购买资产暨关联交易报告书（草案）摘要（修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled as a "发行股份购买资产暨关联交易报告书（草案）摘要（修订稿）" which translates to "Report on Issuance of Shares to Purchase Assets and Related Party Transactions (Draft) Summary (Revised)". It details a transaction involving issuance of shares to purchase assets, including descriptions of the transaction parties, asset valuations, pricing, and regulatory approvals. The document includes extensive financial and transaction details related to a capital raising and asset acquisition event. It is not a full annual or interim report, nor an earnings release or audit report. It is a detailed capital/financing update related to issuance of shares and asset purchase. Therefore, the document fits best under the category Capital/Financing Update (CAP). The document length (15,000 characters) and content confirm it is a substantive report, not a mere announcement or certification.
2018-06-27 Chinese
发行股份购买资产暨关联交易报告书（草案）（修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled "发行股份购买资产暨关联交易报告书（草案）（修订稿）" which translates to "Report on Issuance of Shares to Purchase Assets and Related Party Transactions (Draft) (Revised)". It details a major asset acquisition transaction involving issuance of shares to purchase 100% equity of several companies, including financial data, valuation reports, transaction pricing, share issuance details, lock-up periods, and approvals required. The document includes audited financial data, transaction structure, pricing adjustment mechanisms, and regulatory approvals pending. It is a comprehensive report on a significant corporate transaction involving issuance of shares to purchase assets and related party transactions, which is a capital/financing update rather than a full annual or interim report. It is not an announcement of a report publication, nor a proxy solicitation, nor a regulatory filing or earnings release. The document is substantive and detailed, exceeding 5,000 characters, and contains financial and transaction details. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2018-06-27 Chinese
COFCO Biochemical Holdings Limited审计报告
Regulatory Filings
2018-06-27 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.